Loading
NASDAQHealthcareMedical - Healthcare Information Services
Latest quote
$8.36
+$0.27 · +3.34%
SOPHiA GENETICS S.A. operates as a specialized company within the healthcare technology sector. The firm provides the SOPHiA DDM platform, a cloud-native Software-as-a-Service (SaaS) solution engineered to analyze diverse multimodal datasets and various diagnostic inputs, thereby extracting valuable insights. This platform, together with its related offerings and services, is widely adopted by hospitals, laboratories, and biopharmaceutical organizations across the globe. Founded in 2011, SOPHiA GENETICS S.A. is headquartered in Saint-Sulpice, Switzerland.
Previous close
$8.36
+$0.27 · +3.34%
After-hours
$8.50
+$0.14 · +1.67%
Sep 8, 7:30 PM ET
Regular session · ET · Market data may be delayed.
SOPHiA GENETICS S.A. operates as a specialized company within the healthcare technology sector. The firm provides the SOPHiA DDM platform, a cloud-native Software-as-a-Service (SaaS) solution engineered to analyze diverse multimodal datasets and various diagnostic inputs, thereby extracting valuable insights. This platform, together with its related offerings and services, is widely adopted by hospitals, laboratories, and biopharmaceutical organizations across the globe. Founded in 2011, SOPHiA GENETICS S.A. is headquartered in Saint-Sulpice, Switzerland.
Day range
Current $8.36
52-week range
Current $8.36
Regular session · ET · Market data may be delayed.
GoAI Score
Hold
Valuation
69
Undervalued
Sentiment
50
Mixed
Risk
46
Elevated Risk
Momentum
79
Gaining
Full GoAI research
Thesis, catalysts, evidence, and risk analysis.
SOPHiA GENETICS S.A. operates as a specialized company within the healthcare technology sector. The firm provides the SOPHiA DDM platform, a cloud-native Software-as-a-Service (SaaS) solution engineered to analyze diverse multimodal datasets and various diagnostic inputs, thereby extracting valuable insights. This platform, together with its related offerings and services, is widely adopted by hospitals, laboratories, and biopharmaceutical organizations across the globe. Founded in 2011, SOPHiA GENETICS S.A. is headquartered in Saint-Sulpice, Switzerland.
Day range
Current $8.36
52-week range
Current $8.36
Profitability as a percentage of reported revenue.
Revenue
Operating income
Net income
| Metric (USD) | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 77.27M USD | 65.17M USD | 62.37M USD | 47.56M USD | 40.45M USD |
| Cost of goods sold | 29.46M USD | 21.24M USD | 19.46M USD | 16.31M USD | 15.23M USD |
| Gross profit | 47.81M USD | 43.94M USD | 42.91M USD | 31.25M USD | 25.22M USD |
| Research and development | 33.57M USD | 34.37M USD | 36.97M USD | 35.37M USD | 26.58M USD |
| Selling, general, and administrative | 85.17M USD | 76.32M USD | 81.72M USD | 84.08M USD | 70.24M USD |
| Operating expenses | 118.74M USD | 110.51M USD | 117.74M USD | 119.08M USD | 96.71M USD |
| Interest income | 1.87M USD | 3.36M USD | 4.55M USD | 1.32M USD | 20K USD |
| Interest expense | 4.55M USD | 1.91M USD | 588K USD | 639K USD | 658K USD |
| Depreciation and amortization | 9.53M USD | 8.6M USD | 8.34M USD | 5.57M USD | 3.61M USD |
| Operating income | −70.93M USD | −66.57M USD | −74.83M USD | −87.82M USD | −71.49M USD |
| Net income | −79M USD | −62.49M USD | −78.98M USD | −87.45M USD | −73.68M USD |
Company facts updated Sep 9, 2026.
Recent quarterly results
Recent quarterly results
Third-party consensus; not a GoAI recommendation.
Average target
$11.50
37.56% upsideFunds reporting this stock among their holdings, ordered by reported position size.
Fidelity Nasdaq Composite Index ETFONEQ
Harbor Health Care ETF (MEDI)MEDI
Acuitas Small Cap Active ETFAIMSAI-generated and delayed market data for informational and educational purposes only. Not investment advice.
